Compare CURV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURV | STIM |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | 7590 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.0M | 105.5M |
| IPO Year | 2021 | 2018 |
| Metric | CURV | STIM |
|---|---|---|
| Price | $1.25 | $1.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $1.59 | ★ $7.00 |
| AVG Volume (30 Days) | 204.2K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.36 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,103,737,000.00 | $52,776,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | N/A | $10.87 |
| P/E Ratio | $125.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $1.17 |
| 52 Week High | $6.95 | $5.34 |
| Indicator | CURV | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 60.33 | 42.80 |
| Support Level | $0.96 | $1.22 |
| Resistance Level | $1.41 | $1.46 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 74.28 | 40.35 |
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.